These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28472340)

  • 21. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximizing the Utility of Cancer Transcriptomic Data.
    Xiang Y; Ye Y; Zhang Z; Han L
    Trends Cancer; 2018 Dec; 4(12):823-837. PubMed ID: 30470304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION.
    Danaee P; Ghaeini R; Hendrix DA
    Pac Symp Biocomput; 2017; 22():219-229. PubMed ID: 27896977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoINcIDE: A framework for discovery of patient subtypes across multiple datasets.
    Planey CR; Gevaert O
    Genome Med; 2016 Mar; 8(1):27. PubMed ID: 26961683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.
    Uechi L; Vasudevan S; Vilenski D; Branciamore S; Frankhouser D; O'Meally D; Meshinchi S; Marcucci G; Kuo YH; Rockne R; Kravchenko-Balasha N
    NPJ Syst Biol Appl; 2024 Mar; 10(1):32. PubMed ID: 38527998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
    Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
    Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OralExplorer: a web server for exploring the mechanisms of oral inflammatory diseases.
    Lin W; Yang H; Lin J; Yang X; Liao Z; Zheng Y; Luo P; Liu C
    J Transl Med; 2024 Mar; 22(1):282. PubMed ID: 38491529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.
    Fu J; Khaybullin R; Zhang Y; Xia A; Qi X
    BMC Cancer; 2015 Jun; 15():473. PubMed ID: 26084486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
    Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
    Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mining functionally relevant gene sets for analyzing physiologically novel clinical expression data.
    Turcan S; Vetter DE; Maron JL; Wei X; Slonim DK
    Pac Symp Biocomput; 2011; ():50-61. PubMed ID: 21121032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic stromal gene signatures in breast cancer.
    Winslow S; Leandersson K; Edsjö A; Larsson C
    Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy.
    Pfefferle AD; Spike BT; Wahl GM; Perou CM
    Breast Cancer Res Treat; 2015 Jan; 149(2):425-37. PubMed ID: 25575446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KM-express: an integrated online patient survival and gene expression analysis tool for the identification and functional characterization of prognostic markers in breast and prostate cancers.
    Chen X; Miao Z; Divate M; Zhao Z; Cheung E
    Database (Oxford); 2018 Jan; 2018():. PubMed ID: 29992322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RosettaSX: Reliable gene expression signature scoring of cancer models and patients.
    Kreis J; Nedić B; Mazur J; Urban M; Schelhorn SE; Grombacher T; Geist F; Brors B; Zühlsdorf M; Staub E
    Neoplasia; 2021 Nov; 23(11):1069-1077. PubMed ID: 34583245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of gene-expression signatures in early stage breast cancer.
    Kwa M; Makris A; Esteva FJ
    Nat Rev Clin Oncol; 2017 Oct; 14(10):595-610. PubMed ID: 28561071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. paraGSEA: a scalable approach for large-scale gene expression profiling.
    Peng S; Yang S; Bo X; Li F
    Nucleic Acids Res; 2017 Sep; 45(17):e155. PubMed ID: 28973463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
    Li D; Xia H; Li ZY; Hua L; Li L
    Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
    Jézéquel P; Loussouarn D; Guérin-Charbonnel C; Campion L; Vanier A; Gouraud W; Lasla H; Guette C; Valo I; Verrièle V; Campone M
    Breast Cancer Res; 2015 Mar; 17():43. PubMed ID: 25887482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
    Wang Q; Zhang L; Yan Z; Xie L; An Y; Li H; Han Y; Zhang G; Dong H; Zheng H; Zhu W; Li Y; Wang Y; Guo X
    Future Oncol; 2019 Nov; 15(32):3693-3699. PubMed ID: 31512935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.